Centene Management

Management criteria checks 1/4

Centene's CEO is Sarah London, appointed in Mar 2022, has a tenure of 2.08 years. total yearly compensation is $18.56M, comprised of 7.5% salary and 92.5% bonuses, including company stock and options. directly owns 0.018% of the company’s shares, worth R$37.67M. The average tenure of the management team and the board of directors is 2.5 years and 2.4 years respectively.

Key information

Sarah London

Chief executive officer

US$18.6m

Total compensation

CEO salary percentage	7.5%
CEO tenure	2.1yrs
CEO ownership	0.02%
Management average tenure	2.5yrs
Board average tenure	2.4yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Sarah London's remuneration changed compared to Centene's earnings?
Date	Total Compensation	Salary	Company Earnings
Dec 31 2023	US$19m	US$1m	US$3b
Sep 30 2023	n/a	n/a	US$2b
Jun 30 2023	n/a	n/a	US$3b
Mar 31 2023	n/a	n/a	US$1b
Dec 31 2022	US$13m	US$1m	US$1b
Sep 30 2022	n/a	n/a	US$2b
Jun 30 2022	n/a	n/a	US$2b
Mar 31 2022	n/a	n/a	US$1b
Dec 31 2021	US$15m	US$978k	US$1b

Compensation vs Market: Sarah's total compensation ($USD18.56M) is above average for companies of similar size in the BR market ($USD6.04M).

Compensation vs Earnings: Sarah's compensation has increased by more than 20% in the past year.

CEO

Sarah London (42 yo)

2.1yrs

Tenure

US$18,556,966

Compensation

Ms. Sarah M. London has been the Chief Executive Officer of Centene Corporation since March 21, 2022 and serves as its Director since September 2021. She served as President of Health Care Enterprises and...

Leadership Team

Name	Position	Tenure	Compensation	Ownership
Sarah London	CEO & Director	2.1yrs	US$18.56m	0.018% $ 37.7m
Kenneth Fasola	President	1.3yrs	US$10.62m	0.010% $ 21.6m
Andrew Asher	Executive VP & CFO	2.9yrs	US$9.91m	0.036% $ 75.3m
Christopher Koster	Executive VP	4.2yrs	US$4.84m	0.017% $ 36.3m
David Thomas	CEO of Markets & Medicaid	5.3yrs	US$6.20m	0.0089% $ 18.6m
Susan Smith	Chief Operating Officer	less than a year	no data	no data
Katie Casso	Senior VP	3yrs	no data	0.0053% $ 11.1m
Brian LeClaire	Chief Information Officer	1.3yrs	no data	no data
Jennifer Gilligan	Senior Vice President of Investor Relations	4yrs	no data	no data
Ashlee Knuckey	Chief Risk	1.6yrs	no data	no data
Shannon Susko	Senior VP & Chief Communications Officer	less than a year	no data	no data
Suzy DePrizio	Senior VP & Chief Marketing Officer	2.9yrs	no data	no data

2.5yrs

Average Tenure

55.5yo

Average Age

Experienced Management: C1NC34's management team is considered experienced (2.5 years average tenure).

Board Members

Name	Position	Tenure	Compensation	Ownership
Sarah London	CEO & Director	2.6yrs	US$18.56m	0.018% $ 37.7m
Monte Ford	Independent Director	1.4yrs	US$324.98k	0.00026% $ 543.5k
Frederick Eppinger	Independent Chairman	18yrs	US$537.45k	0.032% $ 67.0m
Christopher Coughlin	Independent Director	2.3yrs	US$369.98k	0.0037% $ 7.7m
H. Dallas	Lead Independent Director	4.3yrs	US$474.98k	0.0042% $ 8.7m
Wayne DeVeydt	Independent Director	2.3yrs	US$372.48k	0.0014% $ 2.9m
Theodore Samuels	Independent Director	2.3yrs	US$349.98k	0.0047% $ 9.8m
Kenneth Burdick	Director	2.3yrs	US$1.25m	0.083% $ 172.6m
Jessica Blume	Independent Director	6.2yrs	US$344.98k	0.0035% $ 7.4m
Lori Robinson	Independent Director	4.5yrs	US$299.98k	0.0016% $ 3.3m

2.4yrs

Average Tenure

64yo

Average Age

Experienced Board: C1NC34's board of directors are not considered experienced ( 2.4 years average tenure), which suggests a new board.

Centene Management

Management criteria checks 1/4

Key information

Recent management updates

Centene Corporation, Annual General Meeting, May 14, 2024

Centene Corporation Announces Appointment of Michael A. Carson as President and Chief Executive Officer of Its Medicare Business

Centene Corporation Announces the Appointment of Susan Smith as Chief Operating Officer, Effective January 1, 2024

Centene Corporation Names Wade Rakes as Chief Growth Officer

Centene Corporation Appoints T. Susko as Its Senior Vice President and Chief Communications Officer

Centene Corporation Announces Resignation of James E. Murray as Chief Operating Officer

Recent updates

Centene Corporation, Annual General Meeting, May 14, 2024

Centene Corporation to Report Q1, 2024 Results on Apr 26, 2024

Centene Corporation Increases Premium and Service Revenues Guidance for the Fiscal Year 2024

Centene Corporation Announces Appointment of Michael A. Carson as President and Chief Executive Officer of Its Medicare Business

Pure Health LLC completed the acquisition of Circle Health Group Limited from Centene Corporation (NYSE:CNC).

Centene Corporation to Report Fiscal Year 2023 Results on Feb 06, 2024

Centene Corporation Provides Earnings Guidance for the Fiscal Year 2024

Centene Corporation Announces the Appointment of Susan Smith as Chief Operating Officer, Effective January 1, 2024

Centene Corporation Provides Earnings Guidance for the Full Year 2023

Centene Corporation Names Wade Rakes as Chief Growth Officer

Centene Corporation to Report Q3, 2023 Results on Oct 24, 2023

Pure Health LLC agreed to acquire Circle Health Group Limited from Centene Corporation (NYSE:CNC) for an enterprise value of approximately $1.2 billion.

Centene Corporation Provides Earnings Guidance for the Full Year 2023

Centene Corporation to Report Q2, 2023 Results on Jul 28, 2023

New Mountain Capital, L.L.C. acquired Apixio, Inc. from Centene Corporation.

Centene Corporation Appoints T. Susko as Its Senior Vice President and Chief Communications Officer

Centene Corporation Announces Resignation of James E. Murray as Chief Operating Officer

New Mountain Capital, L.L.C. agreed to acquire Apixio, Inc. from Centene Corporation (NYSE : CNC).

Centene to Divest AI Platform Apixio

Centene Corporation Provides Earnings Guidance for the Full Year 2023

Centene Corporation to Report Fiscal Year 2022 Results on Feb 07, 2023

Centene Corporation Announces Management Changes

Vivalto Santé SA completed the acquisition of Torrejon Salud, S.A. from Centene Corporation (NYSE:CNC).

Vivalto Santé SA completed the acquisition of Ribera Salud, S.A from Centene Corporation (NYSE:CNC).

Centene Corporation Appoints Monte Ford to Board of Directors

Centene Corporation Provides Earnings Guidance for the Full Year 2022

Centene Corporation to Report Q3, 2022 Results on Oct 25, 2022

Centene Corporation Appoints Ashlee Knuckey as Chief Ethics and Compliance Officer

Centene Corporation Announces James Dallas to Step Down as Chairman of the Board

Vivalto Sante Investissement entered into agreement to acquire Ribera Salud, S.A from Centene Corporation (NYSE:CNC) on July 25, 2022.

Vivalto Santé SA agreed to acquire SPANISH AND CENTRAL EUROPEAN BUSINESSES Of CENTENE from Centene Corporation (NYSE:CNC).

A consortium of The Vistria Group, LLC, General Atlantic Service Company, L.P. and Nautic Partners, LLC completed the acquisition of PANTHERx Rare, LLC from Centene Corporation (NYSE:CNC).

Centene Corporation to Report Q2, 2022 Results on Jul 26, 2022

Centene Corporation Revises Revenue Guidance for the Fiscal Year 2022

A consortium of The Vistria Group, LLC, General Atlantic Service Company, L.P. and Nautic Partners, LLC signed a definitive agreement to acquire PANTHERx Rare, LLC from Centene Corporation (NYSE:CNC).

Centene Corporation Provides Earnings Guidance for the Full Year 2022

Centene Corporation Announces Resignation of Leslie V. Norwalk, Esq. as A Member of the Board

Centene Corporation Announces Executive Changes

Centene Corporation Provides Earnings Guidance for the Full Year 2022

Centene Reportedly Drew Takeover Interest from Cigna in Recent Months

Centene Corporation (NYSE:CNC) completed the acquisition of Magellan Health, Inc. (NasdaqGS:MGLN) from a group of shareholders.

Centene Corporation Reaffirms earnings Guidance for 2021; Provides Earnings Guidance for 2022

Valtruis, Oak HC/FT Partners LLC, HLM Venture Partners and Founders of Rubicon completed the acquisition of an unknown majority stake in U.S. Medical Management, LLC from Centene Corporation (NYSE:CNC).

Centene Corporation(NYSE:CNC) dropped from Russell 3000 Growth Index

Centene Corporation(NYSE:CNC) dropped from Russell Top 200 Growth Index

Centene Corporation Maintains Earnings Guidance for the Year 2021

Centene Corporation Announces Nationwide Vaccination Education and Outreach Initiative

Centene Corporation Updates Annual Guidance for the Year 2021

Centene Corporation to Report Q1, 2021 Results on Apr 27, 2021

Centene Corporation Announces Executive Changes

Centene Corporation Announces Management Changes

Centene Corporation Announces Earnings Guidance for the Year 2021

Zyter LLC acquired Casenet, LLC from Centene Corporation (NYSE:CNC).

Centene Corporation (NYSE:CNC) entered into a definitive merger agreement to acquire Magellan Health, Inc. (NasdaqGS:MGLN) from Starboard Value LP and others for $2.5 billion.

Centene Corporation (NYSE:CNC) completed the acquisition of PANTHERx Rare, LLC.

Centene Corporation (NYSE:CNC) signed a definitive agreement to acquire PANTHERx Rare, LLC.

Centene Appoints Brent Layton to Executive Vice President, Markets, Products, International, and Chief Business Development Officer

Centene Corporation (NYSE:CNC) agreed to acquire Apixio, Inc.

Centene Announces a Collaboration with AT&T to Offer Healthcare Providers Access to FirstNet

Centene Corporation to Report Q3, 2020 Results on Oct 27, 2020

Centene Corporation to Report Q2, 2020 Results on Jul 28, 2020

Centene Corporation(NYSE:CNC) dropped from Russell Midcap Growth Index

CEO Compensation Analysis

CEO

Tenure

Compensation

Leadership Team

Average Tenure

Average Age